A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb Spasticity

NCT03261167 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity, Post-Stroke

Interventions

DRUG: Botulinum toxin A (GSK1358820)
DRUG: Placebo

Sponsor

GlaxoSmithKline